Crown Reserve Acquisition Corp. I（CRAC）の株式分析

AI分析 of Crown Reserve Acquisition Corp. I (CRAC)

中立

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.

バリュエーション指標

Crown Reserve Acquisition Corp. I（CRAC）の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E

現在のP/E

0.00

予想EV/EBITDA

5年平均 EV/EBITDA

現在のEV/EBITDA

0.00

予想PSR

5年平均 P/S

現在のP/S

0.00

CRAC を保有するクジラ

W

W. R. Berkley Corporation

+ を保有CRAC

-1.34%

3か月リターン

P

Polar Asset Management Partners Inc.

+ を保有CRAC

-2.91%

3か月リターン

CRAC のよくある質問 — Alphio AI が回答

Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.